Related Experiment Video
Updated: Mar 20, 2026
07:56
A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices
Published on: August 11, 2021
3.9K
Exogenous dopamine reduces GABA receptor availability in the human brain
Hans C Lou1, Astrid Rosenstand2, David J Brooks1
1CFIN and Pet Center Aarhus University Norregade 44 8000 Aarhus Denmark.
Brain and Behavior
|June 2, 2016
Summary
Dopamine challenge increases GABA system activity in the human brain, specifically in the medial prefrontal anterior cingulate cortex. This study provides direct evidence of dopamine and GABA interaction in the human brain.
Area of Science:
- Neuroscience
- Neurochemistry
Background:
- Dopamine release is known to stimulate conscious self-monitoring via gamma oscillations in the medial prefrontal/anterior cingulate cortex.
- The GABAergic system is implicated in generating these oscillations, but the interaction between dopamine and GABA in humans remains unproven.
Purpose of the Study:
- To investigate the hypothesis that dopamine challenge directly stimulates the GABA system in the medial prefrontal/anterior cingulate region of the human brain.
Main Methods:
- Utilized positron emission tomography (PET) with the GABA receptor α1/α5 subtype ligand [(11)C] Ro15-4513.
- Assessed changes in GABA receptor availability following oral administration of levodopa in a double-blind, controlled study.
Main Results:
- Provided the first direct evidence of dopamine-GABA coupling in the human cerebral cortex, particularly the medial prefrontal anterior cingulate region.
- Demonstrated that exogenous dopamine administration led to a decrease in [(11)C] Ro15-4513 binding, indicating reduced α1 subtype availability in GABA complexes.
Conclusions:
- Exogenous dopamine increases GABAergic activity in the human brain, specifically in the medial prefrontal anterior cingulate cortex.
- This finding establishes a direct link between the dopaminergic and GABAergic systems in human cortical function.
Related Concept Videos
01:29Drugs Affecting Neurotransmitter Synthesis
2.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.4K
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
1.6K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.6K
01:20Desensitization and Tachyphylaxis
3.3K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
3.3K
01:21Drugs Affecting Neurotransmitter Release or Uptake
1.8K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.8K
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
4.6K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
4.6K
01:26Neurochemical Transmission: Sites of Drug Action
3.9K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
3.9K